HRG-2101

N/A

Report date: 2023/11/07 20:06:51
NME

Base Information

Drug NameHRG-2101
Drug Alias NameHRG-2101
ClassificationSmall molecules
Mechanisms of ActionTransforming growth factor beta 1 inhibitorsTumor necrosis factor α inhibitors
TargetsTransforming growth factor beta 1Tumor necrosis factor α
Therapy Area/IndicationsIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesJiangsu Hengrui Medicine Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJiangsu Hengrui Medicine Co Ltd
Active IndicationsN/A
Inactive IndicationsIdiopathic Pulmonary Fibrosis

Other Information

ATC CodeN/A
Related LinksN/A